about
The role of heat shock protein 70 (Hsp70) in radiation-induced immunomodulationIdentification of a rat bone marrow-derived dendritic cell population which secretes both IL-10 and IL-12: evidence against a reciprocal relationship between IL-10 and IL-12 secretionTargeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody.gEM/GANN: A multivariate computational strategy for auto-characterizing relationships between cellular and clinical phenotypes and predicting disease progression time using high-dimensional flow cytometry data.HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancerTumor imaging and targeting potential of an Hsp70-derived 14-mer peptide.Heat shock proteins, anti-heat shock protein reactivity and allograft rejection.Prostate cancer: Important steps and considerations in the design of therapeutic vaccinesHeat shock proteins as regulators of the immune response.Facets of heat shock protein 70 show immunotherapeutic potential.The stress protein gp96 is not an activator of resting rat bone marrow-derived dendritic cells, but is a costimulator and activator of CD3+ T cells.Administration of the stress protein gp96 prolongs rat cardiac allograft survival, modifies rejection-associated inflammatory events, and induces a state of peripheral T-cell hyporesponsivenessImmune Cell Phenotyping Using Flow Cytometry.Proteotoxic stress and circulating cell stress proteins in the cardiovascular diseases.Prediction of Pathological Stage in Patients with Prostate Cancer: A Neuro-Fuzzy Model.A non-receptor-mediated mechanism for internalization of molecular chaperonesThe dual immunoregulatory roles of stress proteins.Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.Tumour infiltrating host cells and their significance for hyperthermia.Molecular chaperones and protein-folding catalysts as intercellular signaling regulators in immunity and inflammation.Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies.Dual role of heat shock proteins (HSPs) in anti-tumor immunity.Extracellular cell stress proteins as biomarkers of human disease.High-dose leptin activates human leukocytes via receptor expression on monocytes.A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics.Influence of opioids on immune function in patients with cancer pain: from bench to bedside.Controlling the dynamics of cell transition in heterogeneous cultures using surface chemistry.Clinically relevant concentrations of opioids for in vitro studies.The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice.Frontiers research topic: radiation-induced effects and the immune system.A novel expression and purification system for the production of enzymatic and biologically active human granzyme B.SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis.The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions?Regulation of lacrimal gland immune responses.HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis.Guidelines for the use of flow cytometry and cell sorting in immunological studies.Heparin modulation of cellular proliferative responses: kinetic and concentration dependency.Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.Influence of tumors on protective anti-tumor immunity and the effects of irradiation.
P50
Q28086922-1ACB4333-0BD4-4943-B842-19629DF2E21CQ28582994-010AD00E-9FB5-4CB3-BB13-9B35E85E7F13Q30497901-36CD88AB-481C-4815-9385-EF604C047D51Q30883669-4E2531AB-85F5-480B-8035-82EB88432110Q33613602-A924AB55-CFC2-4511-BD07-67E423A96849Q34104760-D94F9AD9-5DF7-48F5-84D7-8EADD166E961Q34298169-4FF3EE9E-8AD9-47A1-9C14-B8AD87E6B22CQ34373173-BEE05B5F-F7CF-49CD-9DB5-6B25ED3FE272Q35202861-9E5396CC-1EDD-4ED8-A5D8-5F5BB9354EB3Q35206769-DBF0F94A-536A-45CF-9B50-C02E08B2A665Q35239568-33DFC5F8-1789-4632-A410-8ECF697335D0Q35753012-290303E9-FE14-49B3-B6D2-391BFF5DF7C4Q35829022-5213D048-53BE-4684-82F6-611DC8CE7FC3Q35854596-949239B6-7141-49D0-86F3-44D8C4CEDC57Q36039831-6CDB20AF-F274-467B-BBCB-A8BA524D80B8Q36389477-0A453A23-5F20-4CDA-B772-B66DDA372FD4Q37053268-0726195D-ABFE-4D2C-939D-F721D7EF6EBFQ37170876-93F668FF-A59F-415A-ACB6-E9638D5C8721Q37730088-189CBE55-4029-44B7-B037-52B540BF3DD7Q37743010-040A033A-D23E-41B6-8645-D1D9695C5FA8Q37993183-B24A6F40-5000-4445-8F17-9905A3B3B02AQ38026908-31B6C7B0-110E-42B6-BFA6-1CD710F14095Q38268481-85F24D4A-C5CE-4CC6-B778-E65D595CCE1FQ38295956-76FE2D3C-EF86-4A4B-B041-2F06751F1C6DQ38720963-1C72CA30-D256-409B-BDAF-2B5922F2C5FEQ38736927-624B5F19-7BD0-4F04-B1CF-0E4EEA56D922Q38940778-550B3502-4352-4B01-AB4B-31D22CA86B7CQ39008936-D7B23E89-4376-4E68-A6F5-9A8B26C9C138Q39024088-140D1F01-6A67-4567-BB58-54BAD727C3B1Q39043196-4EEFF0D9-8514-4A9B-8030-122D4696A6C2Q39251307-226AE002-6D03-4678-8646-89AD9665D82FQ39514235-43B44413-BB8F-4ABB-86A9-6598AAA9D8FFQ39677335-DE8FD4D5-4FC6-4B11-88DB-CBB1264BC1C9Q40452360-07F2EFD2-3590-40CE-9C3C-6BBB29EBB7ADQ40670988-AC907A7B-DBDB-49E4-9694-E77E5D951C38Q41516658-04352324-7266-49E7-A56B-80E3C97BD96DQ41918189-1A285965-13F8-4417-A57B-85909A3CBB9CQ42034044-3389C2EB-8092-4C37-9024-13EC31FD6BC4Q42432955-513ED502-C39D-4560-A712-B2A94228026AQ42945799-F8167982-2D78-49A1-BF31-7FA45855ECB9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alan G. Pockley
@ast
Alan G. Pockley
@en
Alan G. Pockley
@es
Alan G. Pockley
@nl
type
label
Alan G. Pockley
@ast
Alan G. Pockley
@en
Alan G. Pockley
@es
Alan G. Pockley
@nl
prefLabel
Alan G. Pockley
@ast
Alan G. Pockley
@en
Alan G. Pockley
@es
Alan G. Pockley
@nl
P1053
I-4704-2015
P106
P1153
7007115879
P21
P2798
P31
P3829
P496
0000-0001-9593-6431